Find the best price for your GLP-1 medication
Compare pricing across telehealth providers, pharmacies, and insurance plans for semaglutide, tirzepatide, and the new oral GLP-1s.
Start with a Verified Provider
Side-by-side pricing for the most-prescribed compounded semaglutide and tirzepatide programs. Updated weekly.
Trim Rx
Lowest-cost compounded GLP-1s
Embody GLP-1
Personalized dosing + prior auth support
HealthRX
Transparent monthly pricing, no insurance required
Strut Health
Streamlined intake, ships in days
GLP-1 Industry News & Updates
Stay current on pricing, FDA actions, and provider news. Updated multiple times daily.
Opinion: Burdensome Medicare GLP-1 program may keep patients from accessing $50 per month weight loss drugs
This article from STAT News covers: Opinion: Burdensome Medicare GLP-1 program may keep patients from accessing $50 per month weight loss dr...
August 6, 2026Debunked Episode 29: CMS GLP-1 Drug Pilot Program, RPM Strategy Raise Questions
This article from MedCity News covers: Debunked Episode 29: CMS GLP-1 Drug Pilot Program, RPM Strategy Raise Questions.
August 5, 2026How Policymakers Can Improve Obesity Treatment and Affordability, Per American College of Physicians
This article from MedCity News covers: How Policymakers Can Improve Obesity Treatment and Affordability, Per American College of Physicians.
August 3, 2026STAT+: Eli Lilly to allow more patients to apply for special access to unapproved obesity drug
This article from STAT News covers: STAT+: Eli Lilly to allow more patients to apply for special access to unapproved obesity drug.
July 31, 2026STAT+: Novo Nordisk inflammation-targeting drug misses mark in heart disease study
This article from STAT News covers: STAT+: Novo Nordisk inflammation-targeting drug misses mark in heart disease study.
July 28, 2026Altimmune’s GLP-1 Drug Reduces Heavy Drinking in Alcohol Use Disorder Trial
This article from MedCity News covers: Altimmune’s GLP-1 Drug Reduces Heavy Drinking in Alcohol Use Disorder Trial.
How GLP-1 Price Guide Works
1. Search
Enter your medication or insurance type to see tailored pricing options across providers.
2. Compare
Analyze pricing across retail pharmacies, telehealth subscriptions, and compounding labs side-by-side.
3. Save
Choose the path that fits your budget — insurance, cash-pay, compounded, or savings card.
Featured Comparisons
Current pricing data from national pharmacies and telehealth providers.
Semaglutide
Wegovy® / Ozempic® / Rybelsus®
Tirzepatide
Zepbound® / Mounjaro®
GLP-1 Pills
Wegovy Pill / Foundayo™ / Rybelsus
Compare trusted telehealth providers
Market Intelligence
What's moving in GLP-1 pricing, access, and regulation.
Foundayo™ (orforglipron) now available in the U.S.
Eli Lilly launched Foundayo, the first oral GLP-1 for weight loss that can be taken any time of day without food or water restrictions. This is the second oral GLP-1 option alongside the Wegovy pill, expanding non-injection choices for patients.
Zepbound KwikPen now at self-pay pharmacies
Nationwide availability expands beyond LillyDirect for cash-pay patients.
India GenericsGeneric obesity drugs in India as low as $14/month
Semaglutide patent expiry creates global pricing pressure.
EuropeWegovy drops cold chain requirement in EU
Storage and shipping simplification may signal US changes ahead.
Latest Guides
Practical answers to the questions patients are asking right now.
Can You Drink Alcohol on Semaglutide?
What happens, what's safe, and what your doctor won't always tell you.
Side EffectsHow to Prevent Muscle Loss on GLP-1
Up to 40% of weight lost can be muscle. Here are evidence-based strategies.
EligibilityCan I Qualify with BMI Under 30?
The 30 BMI threshold is only half the story. Here's who actually qualifies.
LifestyleWhat to Eat on GLP-1: Complete Guide
Your appetite is gone but you still need nutrition. Make every calorie count.
"The right medication at the right price — that's what changes everything."
Never overpay for your medication again.
Get instant alerts when providers drop prices or when new generic alternatives hit the market.
Weekly updates. No spam. Unsubscribe anytime.